WuXi Biologics (Cayman) Inc. (2269.HK)
| Previous close | 55.550 |
| Open | 54.900 |
| Bid | 53.850 x 0 |
| Ask | 53.900 x 0 |
| Day's range | 53.300 - 56.400 |
| 52-week range | 35.000 - 103.400 |
| Volume | |
| Avg. volume | 37,116,913 |
| Market cap | 227.435B |
| Beta (5Y monthly) | 1.14 |
| PE ratio (TTM) | 56.74 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Bloomberg
US-China Tech Rivalry Adds to Headaches for Stock Investors
(Bloomberg) -- China’s heated rivalry with the US over tech supremacy is adding fresh pain points to the world’s second-largest stock market, as the Biden administration steps up efforts to reduce economic reliance on the Asian nation. Most Read from BloombergJapan to Restore Visa-Free Travel From Oct. 11 as Covid Pandemic Recedes South Korea President Caught on Hot Mic Insulting US CongressA Great Copper Squeeze Is Coming for the Global EconomyPutin's Order for 300,000 Fighters Drives Russians
- Stockopedia
Brokers bullish on WuXi Biologics (Cayman) shares
The WuXi Biologics (Cayman) (HKG:2269) share price has risen by 41.2% over the past month and it’s currently trading at HK$76.7. For investors considering whet...
- Bloomberg
U.S. to Blacklist DJI and Seven Other China Firms, FT Reports
(Bloomberg) -- Shares of China’s biggest chipmaker and several of its largest pharmaceutical firms sank on Wednesday on fears that Washington will slap investment and export sanctions against more companies. Most Read from BloombergSouth Africa Hospitalization Rate Plunges in Omicron WaveBiden to Issue ‘Stark Warning’ on Vaccination Amid Covid SurgeEngland Has Hundreds of Thousands of New Omicron Cases DailyVaccine Data Gaps Point to Millions More in U.S. Who Lack ShotsThe Five-Day Office Week I
